FDA Approves Unknown Drug — PROVEPHARM SAS
Provepharm SAS announced the FDA approval of new drug application NDA005939, a regulatory milestone likely to bolster the company's pipeline prospects and strengthen its standing with investors.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day